PREDICTORS OF DEVELOPMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B FOLLOWING PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B

被引：0
|
作者：
Peng, Cheng-Yuan [1 ]
Shih, Chao-Jen [1 ]
Lo, Pei-Shuan [1 ]
Huang, Chia-Lin [1 ]
Lai, Hsueh-Chou [1 ]
Su, Wen-Pang [1 ]
Chuang, Po-Heng [1 ]
Kao, Jung-Ta [1 ]
机构：
[1] China Med Univ, China Med Univ Hosp, Dept Internal Med, Div Hepatogastroenterol, Taichung, Taiwan
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1027A / 1028A
页数：2
相关论文
共 50 条
  • [1] HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
    Fried, Michael W.
    Piratvisuth, Teerha
    Lau, George K. K.
    Marcellin, Patrick
    Chow, Wan-Cheng
    Cooksley, Graham
    Luo, Kang-Xian
    Paik, Seung Woon
    Liaw, Yun-Fan
    Button, Peter
    Popescu, Matei
    [J]. HEPATOLOGY, 2008, 47 (02) : 428 - 434
  • [2] Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
    Lau, GKK
    Piratvisuth, T
    Luo, KX
    Marcellin, P
    Thongsawat, S
    Cooksley, G
    Gane, E
    Fried, MW
    Chow, WC
    Paik, SW
    Chang, WY
    Berg, T
    Flisiak, R
    McCloud, P
    Pluck, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2682 - 2695
  • [3] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    [J]. HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
  • [4] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Teerha Piratvisuth
    George Lau
    You-Chen Chao
    Rui Jin
    Anuchit Chutaputti
    Q.-B. Zhang
    Tawesak Tanwandee
    Peter Button
    Matei Popescu
    [J]. Hepatology International, 2008, 2 : 102 - 110
  • [5] Extended Peginterferon Alfa-2a (Pegasys) Therapy in Chinese Patients With HBeAg-Negative Chronic Hepatitis B
    Chen, Xuefu
    Chen, Xiaoping
    Chen, Wenli
    Ma, Xiaojun
    Huang, Jing
    Chen, Ren
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (10) : 1705 - 1713
  • [6] Virological and immunological predictors of long term outcomes of peginterferon alfa-2a therapy for HBeAg-negative chronic hepatitis B
    Lee, I-Cheng
    Su, Chien-Wei
    Lan, Keng-Hsin
    Wang, Yuan-Jen
    Lee, Kuei-Chuan
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (09) : 1676 - 1685
  • [7] Response to peginterferon alfa-2a (40KD) (PEGASYS) treatment in patients with bridging fibrosis in HBeAg-positive and HBeAg-negative chronic hepatitis B
    Cooksley, Graham
    Lau, George
    Marcellin, Patrick
    Piratvisuth, Teerha
    Lai, Ming-Yang
    Bonino, Ferruccio
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A32 - A32
  • [8] Efficacy and safety of peginterferon alfa-2a in Chinese patients with HBeAg-positive chronic hepatitis B
    Xu, D. -Z.
    Xie, Y.
    Wei, L.
    Chen, X. Y.
    Wan, M. -B.
    Wang, Y. -M.
    Wang, L.
    Wei, J.
    Gan, J. -H.
    Tian, D. -Y.
    Zhang, S. -L.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S266 - S266
  • [9] Pegylated interferon alfa-2a therapy for HBeAg-negative chronic hepatitis B in Taiwan
    Lai, H. C.
    Peng, C. Y.
    Su, W. P.
    Chuang, P. H.
    Kao, J. T.
    Chou, J. W.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A175 - A175
  • [10] PEGYLATED INTERFERON ALFA-2A THERAPY FOR HBEAG-NEGATIVE CHRONIC HEPATITIS B IN TAIWAN
    Lai, Hsueh-Chou
    Peng, Cheng-Yuan
    Su, Wen-Pang
    Chuang, Po-Heng
    [J]. HEPATOLOGY, 2010, 52 (04) : 549A - 549A
12345